Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Gemcitabine and Cisplatin in Urothelial Carcinoma
NCT01374789Phase 2Terminated
- Sponsor
- Wisp
- Start
- Jul 2010
- Primary completion
- Mar 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in urothelial carcinoma (UC), sponsored by Wisp. Started Jul 2010; status: terminated.
02
Drugs
panitumumab
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01374789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01374789.